43 Fletcher F. World Aff. 127 (2019)
Key National Security Questions for the Future of Synthetic Biology

handle is hein.journals/forwa43 and id is 129 raw text is: 

          Key National Security

       Questions for the Future

            of Synthetic Biology

                           DIANE DIEULIIS


      The  rapidly advancing  tools of biotechnology, particularly synthetic
 biology, hold great promise for improving life on the planet and finding solu-
 tions to global challenges in the sectors of energy, agriculture, medicine, and
 environmental sustainability. However, evolving synthetic biology capabilities
 can also be used for harm. The focus to date has been on how these capabilities
 could transform the traditional biothreat space, but they are abo enabling a
 growing global bioeconomy, which represents a new security risk landscape that

 Diane DiEuliis is a Senior Research Fellow at the National Defense University. Her
 research areas focus on emerging biological technologies, biodefense, and preparedness
for biothreats. Specific topic areas under this broad research portfolio include dual
use life sciences research, synthetic biology, the U.S. bioeconomy, disaster recovery, and
behavioral, cognitive, and social science as it relates to important aspects of deterrence
andpreparedness. Dr. DiEuliis has several research grants in progress, and guest lectures
in several foundationalprofessional military education courses. Prior to joining ND U,
Dr. DiEuliis was the Deputy Director for Policy, and served as Acting Deputy Assistant
Secretaryfor Policy andPlanning, in the Office oftheAssistant Secretaryfor Preparedness
and Response, U S. Department ofHealth and Human Services. From 2007 to 2011,
Dr. DiEuliis was the Assistant Director for Life Sciences and Behavioral and Social
Sciences in the Office of Science and Technology Policy (OSTP) in the Executive Office
of the President. Prior to working at OSTB Dr. DiEuliis was a program director
at the National Institutes of Health (NIH), where she managed a diverse portfolio
of neuroscience research in neurodegenerative diseases. She completed a fellowship at
the University of Pennsylvania in the Center for Neurodegenerative Disease Research,
and  completed her postdoctoral research in the NIH Intramural research program,
where she focused on cellular and molecular neuroscience. Dr. DiEuliis has a Ph.D. in
biology from the University of Delaware, in Newark, Delaware.

VOL.43:I  WINTER   2019

What Is HeinOnline?

HeinOnline is a subscription-based resource containing nearly 2,700 academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.

Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline with pricing starting as low as $29.95

Access to this content requires a subscription. Please visit the following page to request a quote or trial:

Already a HeinOnline Subscriber?